These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8540753)

  • 1. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): a potential topical therapy for herpes simplex virus infection.
    Bridges CG; Ahmed SP; Sunkara PS; McCarthy JR; Tyms AS
    Antiviral Res; 1995 Aug; 27(4):325-34. PubMed ID: 8540753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
    Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
    Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
    J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.
    Yoshida Y; Yamamura J; Sato H; Koyasu M; Obara Y; Sekiguchi H; Kawana T; Shiraki K
    J Dermatol Sci; 1996 Dec; 13(3):237-41. PubMed ID: 9023706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
    Lawetz C; Liuzzi M
    Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
    Lebel A; Boivin G
    J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of eugenol on human herpesvirus.
    Benencia F; Courrèges MC
    Phytother Res; 2000 Nov; 14(7):495-500. PubMed ID: 11054837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase inhibitors as anti-herpes agents.
    Wnuk SF; Robins MJ
    Antiviral Res; 2006 Sep; 71(2-3):122-6. PubMed ID: 16621038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic topical therapy by acyclovir and A1110U for herpes simplex virus induced zosteriform rash in mice.
    Lobe DC; Spector T; Ellis MN
    Antiviral Res; 1991 Feb; 15(2):87-100. PubMed ID: 1650166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice.
    Park HJ; Kurokawa M; Shiraki K; Nakamura N; Choi JS; Hattori M
    Biol Pharm Bull; 2005 Dec; 28(12):2258-62. PubMed ID: 16327161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
    Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
    mBio; 2019 May; 10(3):. PubMed ID: 31088925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir.
    Spector T; Lobe DC; Ellis MN; Blumenkopf TA; Szczech GM
    Antimicrob Agents Chemother; 1992 May; 36(5):934-7. PubMed ID: 1324641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections.
    Prichard MN; Kern ER; Hartline CB; Lanier ER; Quenelle DC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4728-34. PubMed ID: 21788472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase: a new class of antiviral agents.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Grenier L; Llinas-Brunet M; Plante R
    J Med Chem; 1995 Sep; 38(18):3617-23. PubMed ID: 7658449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.
    Bhutta MS; Sausen DG; Reed KM; Gallo ES; Hair PS; Lassiter BP; Krishna NK; Cunnion KM; Borenstein R
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo.
    Liuzzi M; Déziel R; Moss N; Beaulieu P; Bonneau AM; Bousquet C; Chafouleas JG; Garneau M; Jaramillo J; Krogsrud RL
    Nature; 1994 Dec; 372(6507):695-8. PubMed ID: 7990963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
    Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
    Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.